-
1
-
-
0001073023
-
Primary and secondary findings in a series of attempts to transplant cerebral cortex in the albino rat
-
Dunn E.H. Primary and secondary findings in a series of attempts to transplant cerebral cortex in the albino rat. J Comp Neurol 1917, 27:565-582.
-
(1917)
J Comp Neurol
, vol.27
, pp. 565-582
-
-
Dunn, E.H.1
-
2
-
-
0025058215
-
Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease
-
Lindvall O., Brundin P., Widner H., Rehncrona S., Gustavii B., Frackowiak R., et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990, 247:574-577.
-
(1990)
Science
, vol.247
, pp. 574-577
-
-
Lindvall, O.1
Brundin, P.2
Widner, H.3
Rehncrona, S.4
Gustavii, B.5
Frackowiak, R.6
-
3
-
-
0026443974
-
Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46months after transplantation for Parkinson's disease
-
Freed C.R., Breeze R.E., Rosenberg N.L., Schneck S.A., Kriek E., Qi J.X., et al. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46months after transplantation for Parkinson's disease. N Engl J Med 1992, 327:1549-1555.
-
(1992)
N Engl J Med
, vol.327
, pp. 1549-1555
-
-
Freed, C.R.1
Breeze, R.E.2
Rosenberg, N.L.3
Schneck, S.A.4
Kriek, E.5
Qi, J.X.6
-
4
-
-
0027977759
-
Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease
-
Lindvall O., Sawle G., Widner H., Rothwell J.C., Björklund A., Brooks D., et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 1994, 35:172-180.
-
(1994)
Ann Neurol
, vol.35
, pp. 172-180
-
-
Lindvall, O.1
Sawle, G.2
Widner, H.3
Rothwell, J.C.4
Björklund, A.5
Brooks, D.6
-
5
-
-
0028360518
-
Bilateral motor improvement and alteration of l-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon
-
Peschanski M., Defer G., N'Guyen J.P., Ricolfi F., Monfort J.C., Remy P., et al. Bilateral motor improvement and alteration of l-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 1994, 117:487-499.
-
(1994)
Brain
, vol.117
, pp. 487-499
-
-
Peschanski, M.1
Defer, G.2
N'Guyen, J.P.3
Ricolfi, F.4
Monfort, J.C.5
Remy, P.6
-
6
-
-
0030834093
-
Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease
-
Wenning G.K., Odin P., Morrish P., Rehncrona S., Widner H., Brundin P., et al. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol 1997, 42:95-107.
-
(1997)
Ann Neurol
, vol.42
, pp. 95-107
-
-
Wenning, G.K.1
Odin, P.2
Morrish, P.3
Rehncrona, S.4
Widner, H.5
Brundin, P.6
-
7
-
-
0032692348
-
Sequential bilateral transplantation in Parkinson's disease: effects of the second graft
-
Hagell P., Schrag A., Piccini P., Jahanshahi M., Brown R., Rehncrona S., et al. Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain 1999, 122:1121-1132.
-
(1999)
Brain
, vol.122
, pp. 1121-1132
-
-
Hagell, P.1
Schrag, A.2
Piccini, P.3
Jahanshahi, M.4
Brown, R.5
Rehncrona, S.6
-
8
-
-
0033934144
-
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease
-
Brundin P., Pogarell O., Hagell P., Piccini P., Widner H., Schrag A., et al. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 2000, 123:1380-1390.
-
(2000)
Brain
, vol.123
, pp. 1380-1390
-
-
Brundin, P.1
Pogarell, O.2
Hagell, P.3
Piccini, P.4
Widner, H.5
Schrag, A.6
-
9
-
-
0035826089
-
Transplantation of embryonic dopamine neurons for severe Parkinson's disease
-
Freed C.R., Greene P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001, 344:710-719.
-
(2001)
N Engl J Med
, vol.344
, pp. 710-719
-
-
Freed, C.R.1
Greene, P.E.2
Breeze, R.E.3
Tsai, W.Y.4
DuMouchel, W.5
Kao, R.6
-
10
-
-
0042837887
-
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
-
Olanow C.W., Goetz C.G., Kordower J.H., Stoessl A., Sossi V., Brin M.F., et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003, 54:403-414.
-
(2003)
Ann Neurol
, vol.54
, pp. 403-414
-
-
Olanow, C.W.1
Goetz, C.G.2
Kordower, J.H.3
Stoessl, A.4
Sossi, V.5
Brin, M.F.6
-
11
-
-
75149140104
-
Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes
-
Ma Y., Tang C., Chaly T., Greene P., Breeze R., Fahn S., et al. Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes. J Nucl Med 2010, 51:7-15.
-
(2010)
J Nucl Med
, vol.51
, pp. 7-15
-
-
Ma, Y.1
Tang, C.2
Chaly, T.3
Greene, P.4
Breeze, R.5
Fahn, S.6
-
12
-
-
0028911848
-
Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease
-
Kordower J.H., Freeman T.B., Snow B.J., Vingerhoets F.J., Mufson E.J., Sanberg P.R., et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 1995, 332:1118-1124.
-
(1995)
N Engl J Med
, vol.332
, pp. 1118-1124
-
-
Kordower, J.H.1
Freeman, T.B.2
Snow, B.J.3
Vingerhoets, F.J.4
Mufson, E.J.5
Sanberg, P.R.6
-
13
-
-
8944230650
-
Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies
-
Kordower J.H., Rosenstein J.M., Collier T.J., Burke M.A., Chen E.Y., Li J.M., et al. Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J Comp Neurol 1996, 370:203-230.
-
(1996)
J Comp Neurol
, vol.370
, pp. 203-230
-
-
Kordower, J.H.1
Rosenstein, J.M.2
Collier, T.J.3
Burke, M.A.4
Chen, E.Y.5
Li, J.M.6
-
14
-
-
0031922226
-
Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease
-
Kordower J.H., Freeman T.B., Chen E.Y., Mufson E.J., Sanberg P.R., Hauser R.A., et al. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov Disord 1998, 13:383-393.
-
(1998)
Mov Disord
, vol.13
, pp. 383-393
-
-
Kordower, J.H.1
Freeman, T.B.2
Chen, E.Y.3
Mufson, E.J.4
Sanberg, P.R.5
Hauser, R.A.6
-
15
-
-
0033491121
-
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient
-
Piccini P., Brooks D.J., Björklund A., Gunn R.N., Grasby P.M., Rimoldi O., et al. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 1999, 2:1137-1140.
-
(1999)
Nat Neurosci
, vol.2
, pp. 1137-1140
-
-
Piccini, P.1
Brooks, D.J.2
Björklund, A.3
Gunn, R.N.4
Grasby, P.M.5
Rimoldi, O.6
-
16
-
-
0033767269
-
Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts
-
Piccini P., Lindvall O., Björklund A., Brundin P., Hagell P., Ceravolo R., et al. Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol 2000, 48:689-695.
-
(2000)
Ann Neurol
, vol.48
, pp. 689-695
-
-
Piccini, P.1
Lindvall, O.2
Björklund, A.3
Brundin, P.4
Hagell, P.5
Ceravolo, R.6
-
17
-
-
0036307190
-
Dyskinesias following neural transplantation in Parkinson's disease
-
Hagell P., Piccini P., Björklund A., Brundin P., Rehncrona S., Widner H., et al. Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci 2002, 5:627-628.
-
(2002)
Nat Neurosci
, vol.5
, pp. 627-628
-
-
Hagell, P.1
Piccini, P.2
Björklund, A.3
Brundin, P.4
Rehncrona, S.5
Widner, H.6
-
18
-
-
28144432547
-
Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective
-
Hagell P., Cenci M.A. Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective. Brain Res Bull 2005, 68:4-15.
-
(2005)
Brain Res Bull
, vol.68
, pp. 4-15
-
-
Hagell, P.1
Cenci, M.A.2
-
19
-
-
53749091110
-
The synaptic impact of the host immune response in a parkinsonian allograft rat model: influence on graft-derived aberrant behaviors
-
Soderstrom K.E., Meredith G., Freeman T.B., McGuire S.O., Collier T.J., Sortwell C.E., et al. The synaptic impact of the host immune response in a parkinsonian allograft rat model: influence on graft-derived aberrant behaviors. Neurobiol Dis 2008, 32:229-242.
-
(2008)
Neurobiol Dis
, vol.32
, pp. 229-242
-
-
Soderstrom, K.E.1
Meredith, G.2
Freeman, T.B.3
McGuire, S.O.4
Collier, T.J.5
Sortwell, C.E.6
-
20
-
-
29144490744
-
Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats
-
Maries E., Kordower J.H., Chu Y., Collier T.J., Sortwell C.E., Olaru E., et al. Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats. Neurobiol Dis 2006, 21:165-180.
-
(2006)
Neurobiol Dis
, vol.21
, pp. 165-180
-
-
Maries, E.1
Kordower, J.H.2
Chu, Y.3
Collier, T.J.4
Sortwell, C.E.5
Olaru, E.6
-
21
-
-
33646140789
-
The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat
-
Lane E.L., Winkler C., Brundin P., Cenci M.A. The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat. Neurobiol Dis 2006, 22:334-345.
-
(2006)
Neurobiol Dis
, vol.22
, pp. 334-345
-
-
Lane, E.L.1
Winkler, C.2
Brundin, P.3
Cenci, M.A.4
-
22
-
-
0034109726
-
The spectrum of levodopa-induced dyskinesias
-
[discussion S9-11]
-
Fahn S. The spectrum of levodopa-induced dyskinesias. Ann Neurol 2000, 47:S2-S9. [discussion S9-11].
-
(2000)
Ann Neurol
, vol.47
-
-
Fahn, S.1
-
23
-
-
33244459813
-
Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia
-
Carlsson T., Winkler C., Lundblad M., Cenci M.A., Björklund A., Kirik D. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia. Neurobiol Dis 2006, 21:657-668.
-
(2006)
Neurobiol Dis
, vol.21
, pp. 657-668
-
-
Carlsson, T.1
Winkler, C.2
Lundblad, M.3
Cenci, M.A.4
Björklund, A.5
Kirik, D.6
-
24
-
-
67349211457
-
Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease
-
Lane E.L., Brundin P., Cenci M.A. Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease. Neurobiol Dis 2009, 35:42-51.
-
(2009)
Neurobiol Dis
, vol.35
, pp. 42-51
-
-
Lane, E.L.1
Brundin, P.2
Cenci, M.A.3
-
25
-
-
75749097333
-
Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats
-
Soderstrom K.E., O'Malley J.A., Levine N.D., Sortwell C.E., Collier T.J., Steece-Collier K. Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats. Eur J Neurosci 2010, 31:478-490.
-
(2010)
Eur J Neurosci
, vol.31
, pp. 478-490
-
-
Soderstrom, K.E.1
O'Malley, J.A.2
Levine, N.D.3
Sortwell, C.E.4
Collier, T.J.5
Steece-Collier, K.6
-
26
-
-
67349088356
-
Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis
-
Olanow C.W., Gracies J.M., Goetz C.G., Stoessl A.J., Freeman T., Kordower J.H., et al. Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis. Mov Disord 2009, 24:336-343.
-
(2009)
Mov Disord
, vol.24
, pp. 336-343
-
-
Olanow, C.W.1
Gracies, J.M.2
Goetz, C.G.3
Stoessl, A.J.4
Freeman, T.5
Kordower, J.H.6
-
27
-
-
0036830588
-
Dyskinesia after fetal cell transplantation for parkinsonism: a PET study
-
Ma Y., Feigin A., Dhawan V., Fukuda M., Shi Q., Greene P., et al. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann Neurol 2002, 52:628-634.
-
(2002)
Ann Neurol
, vol.52
, pp. 628-634
-
-
Ma, Y.1
Feigin, A.2
Dhawan, V.3
Fukuda, M.4
Shi, Q.5
Greene, P.6
-
28
-
-
77249086109
-
The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease
-
Grealish S., Jönsson M.E., Li M., Kirik D., Björklund A., Thompson L.H. The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease. Brain 2010, 133:482-495.
-
(2010)
Brain
, vol.133
, pp. 482-495
-
-
Grealish, S.1
Jönsson, M.E.2
Li, M.3
Kirik, D.4
Björklund, A.5
Thompson, L.H.6
-
29
-
-
80052541116
-
Dopamine release from serotonergic nerve fibers is reduced in l-DOPA-induced dyskinesia
-
Nevalainen N., af Bjerkén S., Lundblad M., Gerhardt G.A., Strömberg I. Dopamine release from serotonergic nerve fibers is reduced in l-DOPA-induced dyskinesia. J Neurochem 2011, 118:12-23.
-
(2011)
J Neurochem
, vol.118
, pp. 12-23
-
-
Nevalainen, N.1
af Bjerkén, S.2
Lundblad, M.3
Gerhardt, G.A.4
Strömberg, I.5
-
30
-
-
80052521061
-
5-HT(1A) receptor stimulation and l-DOPA-induced dyskinesia in Parkinson's disease: bridging the gap between serotonergic and glutamatergic mechanisms
-
Huot P., Brotchie J.M. 5-HT(1A) receptor stimulation and l-DOPA-induced dyskinesia in Parkinson's disease: bridging the gap between serotonergic and glutamatergic mechanisms. Exp Neurol 2011, 231:195-198.
-
(2011)
Exp Neurol
, vol.231
, pp. 195-198
-
-
Huot, P.1
Brotchie, J.M.2
-
31
-
-
0023265004
-
Continuous dopaminergic stimulation in Parkinson's disease
-
Obeso J.A., Luquin M.R., Vaamonde J., Grandas F., Martinez Lage J.M. Continuous dopaminergic stimulation in Parkinson's disease. Can J Neurol Sci 1987, 14:488-492.
-
(1987)
Can J Neurol Sci
, vol.14
, pp. 488-492
-
-
Obeso, J.A.1
Luquin, M.R.2
Vaamonde, J.3
Grandas, F.4
Martinez Lage, J.M.5
-
32
-
-
0024384156
-
Continuous levodopa infusions to treat complex dystonia in Parkinson's disease
-
Sage J.I., McHale D.M., Sonsalla P., Vitagliano D., Heikkila R.E. Continuous levodopa infusions to treat complex dystonia in Parkinson's disease. Neurology 1989, 39:888-891.
-
(1989)
Neurology
, vol.39
, pp. 888-891
-
-
Sage, J.I.1
McHale, D.M.2
Sonsalla, P.3
Vitagliano, D.4
Heikkila, R.E.5
-
33
-
-
0026494079
-
The rationale for continuous dopaminergic stimulation in patients with Parkinson's disease
-
[discussion 57-60]
-
Sage J.I., Mark M.H. The rationale for continuous dopaminergic stimulation in patients with Parkinson's disease. Neurology 1992, 42:23-28. [discussion 57-60].
-
(1992)
Neurology
, vol.42
, pp. 23-28
-
-
Sage, J.I.1
Mark, M.H.2
-
34
-
-
78249271694
-
Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia
-
Rylander D., Parent M., O'Sullivan S.S., Dovero S., Lees A.J., Bezard E., et al. Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. Ann Neurol 2010, 68:619-628.
-
(2010)
Ann Neurol
, vol.68
, pp. 619-628
-
-
Rylander, D.1
Parent, M.2
O'Sullivan, S.S.3
Dovero, S.4
Lees, A.J.5
Bezard, E.6
-
35
-
-
77957802624
-
Morphological changes in serotonergic neurites in the striatum and globus pallidus in levodopa primed MPTP treated common marmosets with dyskinesia
-
Zeng B.Y., Iravani M.M., Jackson M.J., Rose S., Parent A., Jenner P. Morphological changes in serotonergic neurites in the striatum and globus pallidus in levodopa primed MPTP treated common marmosets with dyskinesia. Neurobiol Dis 2010, 40:599-607.
-
(2010)
Neurobiol Dis
, vol.40
, pp. 599-607
-
-
Zeng, B.Y.1
Iravani, M.M.2
Jackson, M.J.3
Rose, S.4
Parent, A.5
Jenner, P.6
-
36
-
-
0018842575
-
High resolution radioautographic study of the serotonin innervation of the rat corpus striatum after intraventricular administration of [3H]5-hydroxytryptamine
-
Arluison M., de la Manche I.S. High resolution radioautographic study of the serotonin innervation of the rat corpus striatum after intraventricular administration of [3H]5-hydroxytryptamine. Neuroscience 1980, 5:229-240.
-
(1980)
Neuroscience
, vol.5
, pp. 229-240
-
-
Arluison, M.1
de la Manche, I.S.2
-
37
-
-
0027250556
-
Ultrastructure and synaptic targets of the raphe-nigral projection in the rat
-
Corvaja N., Doucet G., Bolam J.P. Ultrastructure and synaptic targets of the raphe-nigral projection in the rat. Neuroscience 1993, 55:417-427.
-
(1993)
Neuroscience
, vol.55
, pp. 417-427
-
-
Corvaja, N.1
Doucet, G.2
Bolam, J.P.3
-
38
-
-
0026569932
-
Ultrastructural analysis of the serotonin hyperinnervation in adult rat neostriatum following neonatal dopamine denervation with 6-hydroxydopamine
-
Descarries L., Soghomonian J.J., Garcia S., Doucet G., Bruno J.P. Ultrastructural analysis of the serotonin hyperinnervation in adult rat neostriatum following neonatal dopamine denervation with 6-hydroxydopamine. Brain Res 1992, 569:1-13.
-
(1992)
Brain Res
, vol.569
, pp. 1-13
-
-
Descarries, L.1
Soghomonian, J.J.2
Garcia, S.3
Doucet, G.4
Bruno, J.P.5
-
39
-
-
0024600493
-
Serotonin innervation in the adult rat neostriatum. II: Ultrastructural features: a radioautographic and immunocytochemical study
-
Soghomonian J.J., Descarries L., Watkins K.C. Serotonin innervation in the adult rat neostriatum. II: Ultrastructural features: a radioautographic and immunocytochemical study. Brain Res 1989, 481:67-86.
-
(1989)
Brain Res
, vol.481
, pp. 67-86
-
-
Soghomonian, J.J.1
Descarries, L.2
Watkins, K.C.3
-
40
-
-
0037195086
-
The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate
-
Fremeau R.T., Burman J., Qureshi T., Tran C.H., Proctor J., Johnson J., et al. The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc Natl Acad Sci USA 2002, 99:14488-14493.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 14488-14493
-
-
Fremeau, R.T.1
Burman, J.2
Qureshi, T.3
Tran, C.H.4
Proctor, J.5
Johnson, J.6
-
41
-
-
0036662899
-
A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons
-
Gras C., Herzog E., Bellenchi G.C., Bernard V., Ravassard P., Pohl M., et al. A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J Neurosci 2002, 22:5442-5451.
-
(2002)
J Neurosci
, vol.22
, pp. 5442-5451
-
-
Gras, C.1
Herzog, E.2
Bellenchi, G.C.3
Bernard, V.4
Ravassard, P.5
Pohl, M.6
-
42
-
-
0038139324
-
Molecular cloning and functional identification of mouse vesicular glutamate transporter 3 and its expression in subsets of novel excitatory neurons
-
Schäfer M.K., Varoqui H., Defamie N., Weihe E., Erickson J.D. Molecular cloning and functional identification of mouse vesicular glutamate transporter 3 and its expression in subsets of novel excitatory neurons. J Biol Chem 2002, 277:50734-50748.
-
(2002)
J Biol Chem
, vol.277
, pp. 50734-50748
-
-
Schäfer, M.K.1
Varoqui, H.2
Defamie, N.3
Weihe, E.4
Erickson, J.D.5
-
43
-
-
0036668641
-
Molecular cloning and functional characterization of human vesicular glutamate transporter 3
-
Takamori S., Malherbe P., Broger C., Jahn R. Molecular cloning and functional characterization of human vesicular glutamate transporter 3. EMBO Rep 2002, 3:798-803.
-
(2002)
EMBO Rep
, vol.3
, pp. 798-803
-
-
Takamori, S.1
Malherbe, P.2
Broger, C.3
Jahn, R.4
-
44
-
-
76649094228
-
VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety
-
Amilhon B., Lepicard E., Renoir T., Mongeau R., Popa D., Poirel O., et al. VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety. J Neurosci 2010, 30:2198-2210.
-
(2010)
J Neurosci
, vol.30
, pp. 2198-2210
-
-
Amilhon, B.1
Lepicard, E.2
Renoir, T.3
Mongeau, R.4
Popa, D.5
Poirel, O.6
-
45
-
-
79952750323
-
Interplay between VGLUT isoforms and endophilin A1 regulates neurotransmitter release and short-term plasticity
-
Weston M.C., Nehring R.B., Wojcik S.M., Rosenmund C. Interplay between VGLUT isoforms and endophilin A1 regulates neurotransmitter release and short-term plasticity. Neuron 2011, 69:1147-1159.
-
(2011)
Neuron
, vol.69
, pp. 1147-1159
-
-
Weston, M.C.1
Nehring, R.B.2
Wojcik, S.M.3
Rosenmund, C.4
-
46
-
-
79952821494
-
From glutamate co-release to vesicular synergy: vesicular glutamate transporters
-
El Mestikawy S., Wallén-Mackenzie A., Fortin G.M., Descarries L., Trudeau L.E. From glutamate co-release to vesicular synergy: vesicular glutamate transporters. Nat Rev Neurosci 2011, 12:204-216.
-
(2011)
Nat Rev Neurosci
, vol.12
, pp. 204-216
-
-
El Mestikawy, S.1
Wallén-Mackenzie, A.2
Fortin, G.M.3
Descarries, L.4
Trudeau, L.E.5
-
47
-
-
77649250295
-
Vesicular glutamate transporter 3-expressing nonserotonergic projection neurons constitute a subregion in the rat midbrain raphe nuclei
-
Hioki H., Nakamura H., Ma Y.F., Konno M., Hayakawa T., Nakamura K.C., et al. Vesicular glutamate transporter 3-expressing nonserotonergic projection neurons constitute a subregion in the rat midbrain raphe nuclei. J Comp Neurol 2010, 518:668-686.
-
(2010)
J Comp Neurol
, vol.518
, pp. 668-686
-
-
Hioki, H.1
Nakamura, H.2
Ma, Y.F.3
Konno, M.4
Hayakawa, T.5
Nakamura, K.C.6
-
48
-
-
0028261671
-
Synaptic glutamate release by postnatal rat serotonergic neurons in microculture
-
Johnson M.D. Synaptic glutamate release by postnatal rat serotonergic neurons in microculture. Neuron 1994, 12:433-442.
-
(1994)
Neuron
, vol.12
, pp. 433-442
-
-
Johnson, M.D.1
-
49
-
-
70350132404
-
Fast synaptic subcortical control of hippocampal circuits
-
Varga V., Losonczy A., Zemelman B.V., Borhegyi Z., Nyiri G., Domonkos A., et al. Fast synaptic subcortical control of hippocampal circuits. Science 2009, 326:449-453.
-
(2009)
Science
, vol.326
, pp. 449-453
-
-
Varga, V.1
Losonczy, A.2
Zemelman, B.V.3
Borhegyi, Z.4
Nyiri, G.5
Domonkos, A.6
-
50
-
-
79956095948
-
Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats
-
Dupre K.B., Ostock C.Y., Eskow Jaunarajs K.L., Button T., Savage L.M., Wolf W. Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats. Exp Neurol 2011, 229:288-299.
-
(2011)
Exp Neurol
, vol.229
, pp. 288-299
-
-
Dupre, K.B.1
Ostock, C.Y.2
Eskow Jaunarajs, K.L.3
Button, T.4
Savage, L.M.5
Wolf, W.6
-
51
-
-
28544441892
-
Factors affecting the clinical outcome after neural transplantation in Parkinson's disease
-
Piccini P., Pavese N., Hagell P., Reimer J., Björklund A., Oertel W.H., et al. Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain 2005, 128:2977-2986.
-
(2005)
Brain
, vol.128
, pp. 2977-2986
-
-
Piccini, P.1
Pavese, N.2
Hagell, P.3
Reimer, J.4
Björklund, A.5
Oertel, W.H.6
-
52
-
-
0035871386
-
Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration
-
Kirik D., Winkler C., Björklund A. Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration. J Neurosci 2001, 21:2889-2896.
-
(2001)
J Neurosci
, vol.21
, pp. 2889-2896
-
-
Kirik, D.1
Winkler, C.2
Björklund, A.3
-
53
-
-
0023943663
-
Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease
-
McNeill T.H., Brown S.A., Rafols J.A., Shoulson I. Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease. Brain Res 1988, 455:148-152.
-
(1988)
Brain Res
, vol.455
, pp. 148-152
-
-
McNeill, T.H.1
Brown, S.A.2
Rafols, J.A.3
Shoulson, I.4
-
54
-
-
13244287684
-
Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease
-
Zaja-Milatovic S., Milatovic D., Schantz A.M., Zhang J., Montine K.S., Samii A., et al. Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology 2005, 64:545-547.
-
(2005)
Neurology
, vol.64
, pp. 545-547
-
-
Zaja-Milatovic, S.1
Milatovic, D.2
Schantz, A.M.3
Zhang, J.4
Montine, K.S.5
Samii, A.6
-
55
-
-
20144389550
-
Evidence of a breakdown of corticostriatal connections in Parkinson's disease
-
Stephens B., Mueller A.J., Shering A.F., Hood S.H., Taggart P., Arbuthnott G.W., et al. Evidence of a breakdown of corticostriatal connections in Parkinson's disease. Neuroscience 2005, 132:741-754.
-
(2005)
Neuroscience
, vol.132
, pp. 741-754
-
-
Stephens, B.1
Mueller, A.J.2
Shering, A.F.3
Hood, S.H.4
Taggart, P.5
Arbuthnott, G.W.6
-
56
-
-
31544465246
-
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models
-
Day M., Wang Z., Ding J., An X., Ingham C.A., Shering A.F., et al. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 2006, 9:251-259.
-
(2006)
Nat Neurosci
, vol.9
, pp. 251-259
-
-
Day, M.1
Wang, Z.2
Ding, J.3
An, X.4
Ingham, C.A.5
Shering, A.F.6
-
57
-
-
35348827286
-
Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons
-
Neely M.D., Schmidt D.E., Deutch A.Y. Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons. Neuroscience 2007, 149:457-464.
-
(2007)
Neuroscience
, vol.149
, pp. 457-464
-
-
Neely, M.D.1
Schmidt, D.E.2
Deutch, A.Y.3
-
58
-
-
58149488975
-
Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys
-
Villalba R.M., Lee H., Smith Y. Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys. Exp Neurol 2009, 215:220-227.
-
(2009)
Exp Neurol
, vol.215
, pp. 220-227
-
-
Villalba, R.M.1
Lee, H.2
Smith, Y.3
-
59
-
-
0021676562
-
Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines
-
Freund T.F., Powell J.F., Smith A.D. Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience 1984, 13:1189-1215.
-
(1984)
Neuroscience
, vol.13
, pp. 1189-1215
-
-
Freund, T.F.1
Powell, J.F.2
Smith, A.D.3
-
60
-
-
0021916279
-
Efferent synaptic connections of grafted dopaminergic neurons reinnervating the host neostriatum: a tyrosine hydroxylase immunocytochemical study
-
Freund T.F., Bolam J.P., Björklund A., Stenevi U., Dunnett S.B., Powell J.F., et al. Efferent synaptic connections of grafted dopaminergic neurons reinnervating the host neostriatum: a tyrosine hydroxylase immunocytochemical study. J Neurosci 1985, 5:603-616.
-
(1985)
J Neurosci
, vol.5
, pp. 603-616
-
-
Freund, T.F.1
Bolam, J.P.2
Björklund, A.3
Stenevi, U.4
Dunnett, S.B.5
Powell, J.F.6
-
61
-
-
0021930728
-
Substantia nigra transplants into denervated striatum of the rat: ultrastructure of graft and host interconnections
-
Mahalik T.J., Finger T.E., Stromberg I., Olson L. Substantia nigra transplants into denervated striatum of the rat: ultrastructure of graft and host interconnections. J Comp Neurol 1985, 240:60-70.
-
(1985)
J Comp Neurol
, vol.240
, pp. 60-70
-
-
Mahalik, T.J.1
Finger, T.E.2
Stromberg, I.3
Olson, L.4
-
62
-
-
0023281057
-
Synaptic input and local output of dopaminergic neurons in grafts that functionally reinnervate the host neostriatum
-
Bolam J.P., Freund T.F., Björklund A., Dunnett S.B., Smith A.D. Synaptic input and local output of dopaminergic neurons in grafts that functionally reinnervate the host neostriatum. Exp Brain Res 1987, 68:131-146.
-
(1987)
Exp Brain Res
, vol.68
, pp. 131-146
-
-
Bolam, J.P.1
Freund, T.F.2
Björklund, A.3
Dunnett, S.B.4
Smith, A.D.5
-
63
-
-
0023945243
-
Striatal grafts in rats with unilateral neurostriatal lesions. I: Ultrastructural evidence of afferent synaptic inputs from the host nigrostriatal pathway
-
Clarke D.J., Dunnett S.B., Isacson O., Sirinathsinghji D.J., Björklund A. Striatal grafts in rats with unilateral neurostriatal lesions. I: Ultrastructural evidence of afferent synaptic inputs from the host nigrostriatal pathway. Neuroscience 1988, 24:791-801.
-
(1988)
Neuroscience
, vol.24
, pp. 791-801
-
-
Clarke, D.J.1
Dunnett, S.B.2
Isacson, O.3
Sirinathsinghji, D.J.4
Björklund, A.5
-
64
-
-
0025017670
-
Intrastriatal implants of mesencephalic cell suspensions in weaver mutant mice: ultrastructural relationships of dopaminergic dendrites and axons issued from the graft
-
Triarhou L.C., Brundin P., Doucet G., Norton J., Björklund A., Ghetti B. Intrastriatal implants of mesencephalic cell suspensions in weaver mutant mice: ultrastructural relationships of dopaminergic dendrites and axons issued from the graft. Exp Brain Res 1990, 79:3-17.
-
(1990)
Exp Brain Res
, vol.79
, pp. 3-17
-
-
Triarhou, L.C.1
Brundin, P.2
Doucet, G.3
Norton, J.4
Björklund, A.5
Ghetti, B.6
-
65
-
-
77955625476
-
Presynaptic dopaminergic compartment determines the susceptibility to l-DOPA-induced dyskinesia in rats
-
Ulusoy A., Sahin G., Kirik D. Presynaptic dopaminergic compartment determines the susceptibility to l-DOPA-induced dyskinesia in rats. Proc Natl Acad Sci USA 2010, 107:13159-13164.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 13159-13164
-
-
Ulusoy, A.1
Sahin, G.2
Kirik, D.3
-
66
-
-
58549109655
-
Chronic intermittent l-DOPA treatment induces changes in dopamine release
-
Lundblad M., af Bjerkén S., Cenci M.A., Permerleau F., Gerhardt G.A., Strömberg I. Chronic intermittent l-DOPA treatment induces changes in dopamine release. J Neurochem 2009, 108:998-1008.
-
(2009)
J Neurochem
, vol.108
, pp. 998-1008
-
-
Lundblad, M.1
af Bjerkén, S.2
Cenci, M.A.3
Permerleau, F.4
Gerhardt, G.A.5
Strömberg, I.6
-
67
-
-
18344402736
-
Presynaptic mechanism of motor fluctuations in Parkinson's disease: a probabilistic model
-
de la Fuente-Fernández R., Schulzer M., Mak E., Calne D.B., Stoessl A.J. Presynaptic mechanism of motor fluctuations in Parkinson's disease: a probabilistic model. Brain 2004, 127:888-899.
-
(2004)
Brain
, vol.127
, pp. 888-899
-
-
de la Fuente-Fernández, R.1
Schulzer, M.2
Mak, E.3
Calne, D.B.4
Stoessl, A.J.5
-
68
-
-
51449119648
-
Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion
-
Dal Bo G., Bérubé-Carrière N., Mendez J.A., Leo D., Riad M., Descarries L., et al. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion. Neuroscience 2008, 156:59-70.
-
(2008)
Neuroscience
, vol.156
, pp. 59-70
-
-
Dal Bo, G.1
Bérubé-Carrière, N.2
Mendez, J.A.3
Leo, D.4
Riad, M.5
Descarries, L.6
-
69
-
-
1642309655
-
Dopamine neurons in culture express VGLUT2 explaining their capacity to release glutamate at synapses in addition to dopamine
-
Dal Bo G., St-Gelais F., Danik M., Williams S., Cotton M., Trudeau L.E. Dopamine neurons in culture express VGLUT2 explaining their capacity to release glutamate at synapses in addition to dopamine. J Neurochem 2004, 88:1398-1405.
-
(2004)
J Neurochem
, vol.88
, pp. 1398-1405
-
-
Dal Bo, G.1
St-Gelais, F.2
Danik, M.3
Williams, S.4
Cotton, M.5
Trudeau, L.E.6
-
70
-
-
46749133106
-
Developmental and target-dependent regulation of vesicular glutamate transporter expression by dopamine neurons
-
Mendez J.A., Bourque M.J., Dal Bo G., Bordeau M.L., Danik M., Williams S. Developmental and target-dependent regulation of vesicular glutamate transporter expression by dopamine neurons. J Neurosci 2008, 28:6309-6318.
-
(2008)
J Neurosci
, vol.28
, pp. 6309-6318
-
-
Mendez, J.A.1
Bourque, M.J.2
Dal Bo, G.3
Bordeau, M.L.4
Danik, M.5
Williams, S.6
-
71
-
-
77953766302
-
Dopaminergic terminals in the nucleus accumbens but not the dorsal striatum corelease glutamate
-
Stuber G.D., Hnasko T.S., Britt J.P., Edwards R.H., Bonci A. Dopaminergic terminals in the nucleus accumbens but not the dorsal striatum corelease glutamate. J Neurosci 2010, 30:8229-8233.
-
(2010)
J Neurosci
, vol.30
, pp. 8229-8233
-
-
Stuber, G.D.1
Hnasko, T.S.2
Britt, J.P.3
Edwards, R.H.4
Bonci, A.5
-
72
-
-
33846186743
-
Glutamatergic neurons are present in the rat ventral tegmental area
-
Yamaguchi T., Sheen W., Morales M. Glutamatergic neurons are present in the rat ventral tegmental area. Eur J Neurosci 2007, 25:106-118.
-
(2007)
Eur J Neurosci
, vol.25
, pp. 106-118
-
-
Yamaguchi, T.1
Sheen, W.2
Morales, M.3
-
73
-
-
0037066060
-
Vesicular glutamate transporter DNPI/VGLUT2 mRNA is present in C1 and several other groups of brainstem catecholaminergic neurons
-
Stornetta R.L., Sevigny C.P., Guyenet P.G. Vesicular glutamate transporter DNPI/VGLUT2 mRNA is present in C1 and several other groups of brainstem catecholaminergic neurons. J Comp Neurol 2002, 444:191-206.
-
(2002)
J Comp Neurol
, vol.444
, pp. 191-206
-
-
Stornetta, R.L.1
Sevigny, C.P.2
Guyenet, P.G.3
-
74
-
-
33748449116
-
Particular subpopulations of midbrain and hypothalamic dopamine neurons express vesicular glutamate transporter 2 in the rat brain
-
Kawano M., Kawasaki A., Sakata-Haga H., Fukui Y., Kawano H., Nogami H., et al. Particular subpopulations of midbrain and hypothalamic dopamine neurons express vesicular glutamate transporter 2 in the rat brain. J Comp Neurol 2006, 498:581-592.
-
(2006)
J Comp Neurol
, vol.498
, pp. 581-592
-
-
Kawano, M.1
Kawasaki, A.2
Sakata-Haga, H.3
Fukui, Y.4
Kawano, H.5
Nogami, H.6
-
75
-
-
0032526981
-
Dopamine neurons make glutamatergic synapses in vitro
-
Sulzer D., Joyce M.P., Lin L., Geldwert D., Haber S.N., Hattori T., et al. Dopamine neurons make glutamatergic synapses in vitro. J Neurosci 1998, 18:4588-4602.
-
(1998)
J Neurosci
, vol.18
, pp. 4588-4602
-
-
Sulzer, D.1
Joyce, M.P.2
Lin, L.3
Geldwert, D.4
Haber, S.N.5
Hattori, T.6
-
76
-
-
0034674995
-
Mesoaccumbens dopamine neuron synapses reconstructed in vitro are glutamatergic
-
Joyce M.P., Rayport S. Mesoaccumbens dopamine neuron synapses reconstructed in vitro are glutamatergic. Neuroscience 2000, 99:445-456.
-
(2000)
Neuroscience
, vol.99
, pp. 445-456
-
-
Joyce, M.P.1
Rayport, S.2
-
77
-
-
0742287910
-
Dopamine neurons mediate a fast excitatory signal via their glutamatergic synapses
-
Chuhma N., Zhang H., Masson J., Zhuang X., Sulzer D., Hen R., et al. Dopamine neurons mediate a fast excitatory signal via their glutamatergic synapses. J Neurosci 2004, 24:972-981.
-
(2004)
J Neurosci
, vol.24
, pp. 972-981
-
-
Chuhma, N.1
Zhang, H.2
Masson, J.3
Zhuang, X.4
Sulzer, D.5
Hen, R.6
-
78
-
-
77952595640
-
Glutamatergic signaling by mesolimbic dopamine neurons in the nucleus accumbens
-
Tecuapetla F., Patel J.C., Xenias H., English D., Tadros I., Shah F., et al. Glutamatergic signaling by mesolimbic dopamine neurons in the nucleus accumbens. J Neurosci 2010, 30:7105-7110.
-
(2010)
J Neurosci
, vol.30
, pp. 7105-7110
-
-
Tecuapetla, F.1
Patel, J.C.2
Xenias, H.3
English, D.4
Tadros, I.5
Shah, F.6
-
79
-
-
0033802514
-
GDNF enhances the synaptic efficacy of dopaminergic neurons in culture
-
Bourque M.J., Trudeau L.E. GDNF enhances the synaptic efficacy of dopaminergic neurons in culture. Eur J Neurosci 2000, 12:3172-3180.
-
(2000)
Eur J Neurosci
, vol.12
, pp. 3172-3180
-
-
Bourque, M.J.1
Trudeau, L.E.2
-
80
-
-
80052371058
-
The gray area between synapse structure and function-Gray's synapse types I and II revisited
-
Klemann C.J., Roubos E.W. The gray area between synapse structure and function-Gray's synapse types I and II revisited. Synapse 2011, 65:1222-1230.
-
(2011)
Synapse
, vol.65
, pp. 1222-1230
-
-
Klemann, C.J.1
Roubos, E.W.2
-
81
-
-
77953843122
-
Calcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinson's disease
-
Kobylecki C., Cenci M.A., Crossman A.R., Ravenscroft P. Calcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinson's disease. J Neurochem 2010, 114:499-511.
-
(2010)
J Neurochem
, vol.114
, pp. 499-511
-
-
Kobylecki, C.1
Cenci, M.A.2
Crossman, A.R.3
Ravenscroft, P.4
-
82
-
-
77952551360
-
Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesias
-
Ouattara B., Hoyer D., Grégoire L., Morissette M., Gasparini F., Gomez-Mancilla B., et al. Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesias. Neuroscience 2010, 167:1160-1167.
-
(2010)
Neuroscience
, vol.167
, pp. 1160-1167
-
-
Ouattara, B.1
Hoyer, D.2
Grégoire, L.3
Morissette, M.4
Gasparini, F.5
Gomez-Mancilla, B.6
-
83
-
-
72449160194
-
Synaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate
-
Silverdale M.A., Kobylecki C., Hallett P.J., Li Q., Dunah A.W., Ravenscroft P., et al. Synaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate. Synapse 2010, 64:177-180.
-
(2010)
Synapse
, vol.64
, pp. 177-180
-
-
Silverdale, M.A.1
Kobylecki, C.2
Hallett, P.J.3
Li, Q.4
Dunah, A.W.5
Ravenscroft, P.6
-
84
-
-
0025935249
-
Induction of long-term potentiation is associated with an increase in the number of axospinous synapses with segmented postsynaptic densities
-
Geinisman Y., deToledo-Morrell L., Morrell F. Induction of long-term potentiation is associated with an increase in the number of axospinous synapses with segmented postsynaptic densities. Brain Res 1991, 566:77-88.
-
(1991)
Brain Res
, vol.566
, pp. 77-88
-
-
Geinisman, Y.1
deToledo-Morrell, L.2
Morrell, F.3
-
85
-
-
53749099718
-
Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease
-
Lane E.L., Soulet D., Vercammen L., Cenci M.A., Brundin P. Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease. Neurobiol Dis 2008, 32:220-228.
-
(2008)
Neurobiol Dis
, vol.32
, pp. 220-228
-
-
Lane, E.L.1
Soulet, D.2
Vercammen, L.3
Cenci, M.A.4
Brundin, P.5
-
86
-
-
84856190485
-
Neuroglial plasticity at striatal glutamatergic synapses in Parkinson's disease
-
Villalba R.M., Smith Y. Neuroglial plasticity at striatal glutamatergic synapses in Parkinson's disease. Front Syst Neurosci 2011, 5:68.
-
(2011)
Front Syst Neurosci
, vol.5
, pp. 68
-
-
Villalba, R.M.1
Smith, Y.2
-
87
-
-
80054905220
-
A role for microglia in synaptic plasticity?
-
Tremblay M.è., Majewska A.K. A role for microglia in synaptic plasticity?. Commun Integr Biol 2011, 4:220-222.
-
(2011)
Commun Integr Biol
, vol.4
, pp. 220-222
-
-
Tremblay, M.è.1
Majewska, A.K.2
-
88
-
-
0025061972
-
Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus
-
Tancredi V., Zona C., Velotti F., Eusebi F., Santoni A. Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus. Brain Res 1990, 525:149-151.
-
(1990)
Brain Res
, vol.525
, pp. 149-151
-
-
Tancredi, V.1
Zona, C.2
Velotti, F.3
Eusebi, F.4
Santoni, A.5
-
89
-
-
0016800414
-
Blockade of amine depletion by nisoxetine in comparison to other uptake inhibitors
-
Fuller R.W., Snoddy H.D., Molloy B.B. Blockade of amine depletion by nisoxetine in comparison to other uptake inhibitors. Psychopharmacol Commun 1975, 1:455-464.
-
(1975)
Psychopharmacol Commun
, vol.1
, pp. 455-464
-
-
Fuller, R.W.1
Snoddy, H.D.2
Molloy, B.B.3
-
90
-
-
77955617871
-
Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants
-
Politis M., Wu K., Loane C., Quinn N.P., Brooks D.J., Rehncrona S., et al. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci Transl Med 2010, 2:38ra46.
-
(2010)
Sci Transl Med
, vol.2
-
-
Politis, M.1
Wu, K.2
Loane, C.3
Quinn, N.P.4
Brooks, D.J.5
Rehncrona, S.6
-
91
-
-
80052971467
-
Graft-induced dyskinesias in Parkinson's disease: high striatal serotonin/dopamine transporter ratio
-
Politis M., Oertel W.H., Wu K., Quinn N.P., Pogarell O., Brooks D.J., et al. Graft-induced dyskinesias in Parkinson's disease: high striatal serotonin/dopamine transporter ratio. Mov Disord 2011, 26:1997-2003.
-
(2011)
Mov Disord
, vol.26
, pp. 1997-2003
-
-
Politis, M.1
Oertel, W.H.2
Wu, K.3
Quinn, N.P.4
Pogarell, O.5
Brooks, D.J.6
-
92
-
-
0023764116
-
Buspirone, a new approach to the treatment of anxiety
-
Taylor D.P. Buspirone, a new approach to the treatment of anxiety. FASEB J 1988, 2:2445-2452.
-
(1988)
FASEB J
, vol.2
, pp. 2445-2452
-
-
Taylor, D.P.1
-
93
-
-
0022516864
-
1-(2-Pyrimidinyl)-piperazine as active metabolite of buspirone in man and rat
-
Caccia S., Conti I., Viganó G., Garattini S. 1-(2-Pyrimidinyl)-piperazine as active metabolite of buspirone in man and rat. Pharmacology 1986, 33:46-51.
-
(1986)
Pharmacology
, vol.33
, pp. 46-51
-
-
Caccia, S.1
Conti, I.2
Viganó, G.3
Garattini, S.4
-
94
-
-
0024515183
-
A metabolite of buspirone increases locus coeruleus activity via alpha 2-receptor blockade
-
Engberg G. A metabolite of buspirone increases locus coeruleus activity via alpha 2-receptor blockade. J Neural Transm 1989, 76:91-98.
-
(1989)
J Neural Transm
, vol.76
, pp. 91-98
-
-
Engberg, G.1
-
95
-
-
0030613812
-
Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine and serotonin levels in the frontal cortex of freely-moving rats
-
Golbert A., Rivet J.M., Cistarelli L., Melon C., Millan M.J. Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine and serotonin levels in the frontal cortex of freely-moving rats. J Neurochem 1997, 69:2616-2619.
-
(1997)
J Neurochem
, vol.69
, pp. 2616-2619
-
-
Golbert, A.1
Rivet, J.M.2
Cistarelli, L.3
Melon, C.4
Millan, M.J.5
-
96
-
-
34447627504
-
Dopamine released from 5-HT terminals is the cause of l-DOPA-induced dyskinesia in parkinsonian rats
-
Carta M., Carlsson T., Kirik D., Björklund A. Dopamine released from 5-HT terminals is the cause of l-DOPA-induced dyskinesia in parkinsonian rats. Brain 2007, 130:1819-1833.
-
(2007)
Brain
, vol.130
, pp. 1819-1833
-
-
Carta, M.1
Carlsson, T.2
Kirik, D.3
Björklund, A.4
-
97
-
-
34547115255
-
The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy
-
Eskow K.L., Gupta V., Alam S., Park J.Y., Bishop C. The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy. Pharmacol Biochem Behav 2007, 87:306-314.
-
(2007)
Pharmacol Biochem Behav
, vol.87
, pp. 306-314
-
-
Eskow, K.L.1
Gupta, V.2
Alam, S.3
Park, J.Y.4
Bishop, C.5
-
98
-
-
0021844076
-
Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain
-
Köhler C., Hall H., Ogren S.O., Gawell L. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. Biochem Pharmacol 1985, 34:2251-2259.
-
(1985)
Biochem Pharmacol
, vol.34
, pp. 2251-2259
-
-
Köhler, C.1
Hall, H.2
Ogren, S.O.3
Gawell, L.4
-
99
-
-
0021285442
-
Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum
-
Billard W., Ruperto V., Crosby G., Iorio L.C., Barnett A. Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum. Life Sci 1984, 35:1885-1893.
-
(1984)
Life Sci
, vol.35
, pp. 1885-1893
-
-
Billard, W.1
Ruperto, V.2
Crosby, G.3
Iorio, L.C.4
Barnett, A.5
-
100
-
-
0021041073
-
The striatal cholinergic interneuron: synaptic target of dopaminergic terminals?
-
Lehmann J., Langer S.Z. The striatal cholinergic interneuron: synaptic target of dopaminergic terminals?. Neuroscience 1983, 10:1105-1120.
-
(1983)
Neuroscience
, vol.10
, pp. 1105-1120
-
-
Lehmann, J.1
Langer, S.Z.2
-
101
-
-
0017083355
-
The action of acetylcholine and l-glutamatic acid on rat caudate neurons
-
Bernardi G., Floris V., Marciani M.G., Morocutti C., Stanzione P. The action of acetylcholine and l-glutamatic acid on rat caudate neurons. Brain Res 1976, 114:134-138.
-
(1976)
Brain Res
, vol.114
, pp. 134-138
-
-
Bernardi, G.1
Floris, V.2
Marciani, M.G.3
Morocutti, C.4
Stanzione, P.5
-
102
-
-
0026756764
-
Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes
-
Bernard V., Normand E., Bloch B. Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes. J Neurosci 1992, 12:3591-3600.
-
(1992)
J Neurosci
, vol.12
, pp. 3591-3600
-
-
Bernard, V.1
Normand, E.2
Bloch, B.3
-
103
-
-
33745712929
-
RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion
-
Ding J., Guzman J.N., Tkatch T., Chen S., Goldberg J.A., Elbert P.J., et al. RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion. Nat Neurosci 2006, 9:832-842.
-
(2006)
Nat Neurosci
, vol.9
, pp. 832-842
-
-
Ding, J.1
Guzman, J.N.2
Tkatch, T.3
Chen, S.4
Goldberg, J.A.5
Elbert, P.J.6
-
104
-
-
0035804772
-
Coordinated expression of muscarinic receptor messenger RNAs in striatal medium spiny neurons
-
Yan Z., Flores-Hernandez J., Surmeier D.J. Coordinated expression of muscarinic receptor messenger RNAs in striatal medium spiny neurons. Neuroscience 2001, 103:1017-1024.
-
(2001)
Neuroscience
, vol.103
, pp. 1017-1024
-
-
Yan, Z.1
Flores-Hernandez, J.2
Surmeier, D.J.3
-
105
-
-
0037323215
-
Alterations in nerve terminal glutamate immunoreactivity in the nucleus accumbens and ventral tegmental area following single and repeated doses of cocaine
-
Kozell B., Meshul K. Alterations in nerve terminal glutamate immunoreactivity in the nucleus accumbens and ventral tegmental area following single and repeated doses of cocaine. Psychopharmcology (Berlin) 2003, 165:337-345.
-
(2003)
Psychopharmcology (Berlin)
, vol.165
, pp. 337-345
-
-
Kozell, B.1
Meshul, K.2
-
106
-
-
0942297966
-
Nerve terminal glutamate immunoreactivity in the rat nucleus accumbens and ventral tegmental area after a short withdrawal from cocaine
-
Kozell L.B., Meshul C.K. Nerve terminal glutamate immunoreactivity in the rat nucleus accumbens and ventral tegmental area after a short withdrawal from cocaine. Synapse 2004, 51:224-232.
-
(2004)
Synapse
, vol.51
, pp. 224-232
-
-
Kozell, L.B.1
Meshul, C.K.2
-
107
-
-
0026035230
-
Electron microscopic study of GABA-immunoreactive neuronal processes in the superficial gray layer of the rat superior colliculus: their relationships with degenerating retinal nerve endings
-
Pinard R., Benfares J., Lanoir J. Electron microscopic study of GABA-immunoreactive neuronal processes in the superficial gray layer of the rat superior colliculus: their relationships with degenerating retinal nerve endings. J Neurocytol 1991, 20:262-276.
-
(1991)
J Neurocytol
, vol.20
, pp. 262-276
-
-
Pinard, R.1
Benfares, J.2
Lanoir, J.3
-
108
-
-
31544482776
-
An architectural framework that may lie at the core of the postsynaptic density
-
Baron M.K., Boeckers T.M., Vaida B., Faham S., Gingery M., Sawaya M.R., et al. An architectural framework that may lie at the core of the postsynaptic density. Science 2006, 311:531-535.
-
(2006)
Science
, vol.311
, pp. 531-535
-
-
Baron, M.K.1
Boeckers, T.M.2
Vaida, B.3
Faham, S.4
Gingery, M.5
Sawaya, M.R.6
-
109
-
-
43449130945
-
Synaptic proteomics: current status and quantitative applications
-
Li K.W., Jimenez C.R. Synaptic proteomics: current status and quantitative applications. Expert Rev Proteomics 2008, 5:353-360.
-
(2008)
Expert Rev Proteomics
, vol.5
, pp. 353-360
-
-
Li, K.W.1
Jimenez, C.R.2
-
110
-
-
0034667704
-
Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias
-
Meredith G.E., De Souza I.E., Hyde T.M., Tipper G., Wong M.L., Egan M.F. Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias. J Neurosci 2000, 20:7798-7806.
-
(2000)
J Neurosci
, vol.20
, pp. 7798-7806
-
-
Meredith, G.E.1
De Souza, I.E.2
Hyde, T.M.3
Tipper, G.4
Wong, M.L.5
Egan, M.F.6
-
111
-
-
0030813597
-
A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
-
Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 1997, 25:192-216.
-
(1997)
Brain Res Brain Res Rev
, vol.25
, pp. 192-216
-
-
Pierce, R.C.1
Kalivas, P.W.2
-
112
-
-
79955536839
-
Cholinergic interneurons mediate fast VGluT3-dependent glutamatergic transmission in the striatum
-
Higley M.J., Gittis A.H., Oldenburg I.A., Balthasar N., Seal R.P., Edwards R.H., et al. Cholinergic interneurons mediate fast VGluT3-dependent glutamatergic transmission in the striatum. PLoS One 2011, 6:e19155.
-
(2011)
PLoS One
, vol.6
-
-
Higley, M.J.1
Gittis, A.H.2
Oldenburg, I.A.3
Balthasar, N.4
Seal, R.P.5
Edwards, R.H.6
-
113
-
-
78650359649
-
Cholinergic interneurons control local circuit activity and cocaine conditioning
-
Witten I.B., Lin S.C., Brodsky M., Prakash R., Diester I., Anikeeva P., et al. Cholinergic interneurons control local circuit activity and cocaine conditioning. Science 2010, 330:1677-1681.
-
(2010)
Science
, vol.330
, pp. 1677-1681
-
-
Witten, I.B.1
Lin, S.C.2
Brodsky, M.3
Prakash, R.4
Diester, I.5
Anikeeva, P.6
-
114
-
-
72649106419
-
Rodent models of treatment-induced motor complications in Parkinson's disease
-
Cenci M.A., Ohlin K.E. Rodent models of treatment-induced motor complications in Parkinson's disease. Parkinsonism Relat Disorder 2009, 15:S13-S17.
-
(2009)
Parkinsonism Relat Disorder
, vol.15
-
-
Cenci, M.A.1
Ohlin, K.E.2
-
115
-
-
66149140822
-
The history of organ transplantation in the Baylor Health Care System
-
Klintmalm G.B. The history of organ transplantation in the Baylor Health Care System. Proc (Bayl Univ Med Cent) 2004, 17:23-34.
-
(2004)
Proc (Bayl Univ Med Cent)
, vol.17
, pp. 23-34
-
-
Klintmalm, G.B.1
-
116
-
-
0018778418
-
Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system
-
Pertlow M.J., Freed W.J., Hoffer B.J., Seiger A., Olson L., Wyatt R.J. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 1979, 204:643-647.
-
(1979)
Science
, vol.204
, pp. 643-647
-
-
Pertlow, M.J.1
Freed, W.J.2
Hoffer, B.J.3
Seiger, A.4
Olson, L.5
Wyatt, R.J.6
-
117
-
-
0024362054
-
Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up
-
Lindvall O., Rehncrona S., Brundin P., Gustavii B., Astedt B., Widner H., et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol 1989, 46:615-631.
-
(1989)
Arch Neurol
, vol.46
, pp. 615-631
-
-
Lindvall, O.1
Rehncrona, S.2
Brundin, P.3
Gustavii, B.4
Astedt, B.5
Widner, H.6
-
118
-
-
42249102276
-
Persistent changes in spinal cord gene expression after recovery from inflammatory hyperalgesia: a preliminary study on pain memory
-
Yukhananov R., Kissin I. Persistent changes in spinal cord gene expression after recovery from inflammatory hyperalgesia: a preliminary study on pain memory. BMC Neurosci 2008, 9:32.
-
(2008)
BMC Neurosci
, vol.9
, pp. 32
-
-
Yukhananov, R.1
Kissin, I.2
-
119
-
-
35649010838
-
Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing - remitting experimental autoimmune encephalomyelitis
-
Rasmussen S., Wang Y., Kivisäkk P., Bronson R.T., Meyer N., Imitola J., et al. Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing - remitting experimental autoimmune encephalomyelitis. Brain 2007, 130:2816-2829.
-
(2007)
Brain
, vol.130
, pp. 2816-2829
-
-
Rasmussen, S.1
Wang, Y.2
Kivisäkk, P.3
Bronson, R.T.4
Meyer, N.5
Imitola, J.6
-
120
-
-
0029744885
-
Sounding the alarm: protein kinase cascades activated by stress and inflammation
-
Kyriakis J.M., Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem 1996, 271:24313-24316.
-
(1996)
J Biol Chem
, vol.271
, pp. 24313-24316
-
-
Kyriakis, J.M.1
Avruch, J.2
-
121
-
-
0036389371
-
Transcription factors involved in the pathogenesis of l-DOPA-induced dyskinesia in a rat model of Parkinson's disease
-
Cenci M.A. Transcription factors involved in the pathogenesis of l-DOPA-induced dyskinesia in a rat model of Parkinson's disease. Amino Acids 2002, 23:105-109.
-
(2002)
Amino Acids
, vol.23
, pp. 105-109
-
-
Cenci, M.A.1
-
122
-
-
79960271748
-
Impact of dopamine to serotonin cell ratio in transplants on behavioral recovery and l-DOPA-induced dyskinesia
-
García J., Carlsson T., Döbrössy M., Nikkhah G., Winkler C. Impact of dopamine to serotonin cell ratio in transplants on behavioral recovery and l-DOPA-induced dyskinesia. Neurobiol Dis 2011, 43:576-587.
-
(2011)
Neurobiol Dis
, vol.43
, pp. 576-587
-
-
García, J.1
Carlsson, T.2
Döbrössy, M.3
Nikkhah, G.4
Winkler, C.5
-
123
-
-
69549113043
-
Lack of functional relevance of isolated cell damage in transplants of Parkinson's disease patients
-
Cooper O., Astradsson A., Hallet P., Robertson H., Mendez I., Isacson O. Lack of functional relevance of isolated cell damage in transplants of Parkinson's disease patients. J Neurol 2009, 256:310-316.
-
(2009)
J Neurol
, vol.256
, pp. 310-316
-
-
Cooper, O.1
Astradsson, A.2
Hallet, P.3
Robertson, H.4
Mendez, I.5
Isacson, O.6
-
124
-
-
43249085326
-
Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14years
-
Mendez I., Viñuela A., Astradsson A., Mukhida K., Hallett P., Robertson H., et al. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14years. Nat Med 2008, 14:507-509.
-
(2008)
Nat Med
, vol.14
, pp. 507-509
-
-
Mendez, I.1
Viñuela, A.2
Astradsson, A.3
Mukhida, K.4
Hallett, P.5
Robertson, H.6
-
125
-
-
67650925055
-
Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movement in parkinsonian rats
-
Steece-Collier K., Soderstrom K.E., Collier T.J., Sortwell C.E., Maries-Lad E. Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movement in parkinsonian rats. J Comp Neurol 2009, 515:15-30.
-
(2009)
J Comp Neurol
, vol.515
, pp. 15-30
-
-
Steece-Collier, K.1
Soderstrom, K.E.2
Collier, T.J.3
Sortwell, C.E.4
Maries-Lad, E.5
-
126
-
-
68549099660
-
Priming for l-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats
-
Lane E.L., Vercammen L., Cenci M.A., Brundin P. Priming for l-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats. Exp Neurol 2009, 219:355-358.
-
(2009)
Exp Neurol
, vol.219
, pp. 355-358
-
-
Lane, E.L.1
Vercammen, L.2
Cenci, M.A.3
Brundin, P.4
-
127
-
-
77958523402
-
Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition
-
Paillé V., Picconi B., Bagetta V., Ghiglieri V., Sgobio C., Di Filippo M., et al. Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition. J Neurosci 2010, 30:14182-14193.
-
(2010)
J Neurosci
, vol.30
, pp. 14182-14193
-
-
Paillé, V.1
Picconi, B.2
Bagetta, V.3
Ghiglieri, V.4
Sgobio, C.5
Di Filippo, M.6
-
128
-
-
34249801477
-
The functional impact of the intrastriatal dopamine neuron grafts in parkinsonian rats is reduced with advancing disease
-
Breysse N., Carlsson T., Winkler C., Björklund A., Kirik D. The functional impact of the intrastriatal dopamine neuron grafts in parkinsonian rats is reduced with advancing disease. J Neurosci 2007, 27:5849-5856.
-
(2007)
J Neurosci
, vol.27
, pp. 5849-5856
-
-
Breysse, N.1
Carlsson, T.2
Winkler, C.3
Björklund, A.4
Kirik, D.5
-
129
-
-
0033168820
-
Diminished viability, growth, and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion: an argument for neurotrophic supplementation
-
Collier T.J., Sortwell C.E., Daley B.F. Diminished viability, growth, and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion: an argument for neurotrophic supplementation. J Neurosci 1999, 19:5563-5573.
-
(1999)
J Neurosci
, vol.19
, pp. 5563-5573
-
-
Collier, T.J.1
Sortwell, C.E.2
Daley, B.F.3
-
130
-
-
33947211176
-
Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism
-
Collier T.J., Lipton J., Daley B.F., Palfi S., Chu Y., Sortwell C., et al. Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism. Neurobiol Dis 2007, 26:56-65.
-
(2007)
Neurobiol Dis
, vol.26
, pp. 56-65
-
-
Collier, T.J.1
Lipton, J.2
Daley, B.F.3
Palfi, S.4
Chu, Y.5
Sortwell, C.6
-
131
-
-
79955466566
-
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease
-
de la Fuente-Fernández R., Schulzer M., Kuramoto L., Cragg J., Ramachandiran N., Au W.L., et al. Age-specific progression of nigrostriatal dysfunction in Parkinson's disease. Ann Neurol 2011, 69:803-810.
-
(2011)
Ann Neurol
, vol.69
, pp. 803-810
-
-
de la Fuente-Fernández, R.1
Schulzer, M.2
Kuramoto, L.3
Cragg, J.4
Ramachandiran, N.5
Au, W.L.6
-
132
-
-
53049089585
-
Intermittent l-DOPA treatment differentially alters synaptotagmin 4 and 7 gene expression in the striatum of hemiparkinsonian rats
-
Glavan G. Intermittent l-DOPA treatment differentially alters synaptotagmin 4 and 7 gene expression in the striatum of hemiparkinsonian rats. Brain Res 2008, 1236:216-224.
-
(2008)
Brain Res
, vol.1236
, pp. 216-224
-
-
Glavan, G.1
-
133
-
-
77955828413
-
Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment
-
Belujon P., Lodge D.J., Grace A.A. Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment. Mov Disord 2010, 25:1568-1576.
-
(2010)
Mov Disord
, vol.25
, pp. 1568-1576
-
-
Belujon, P.1
Lodge, D.J.2
Grace, A.A.3
-
134
-
-
34547484764
-
Serotonin neuron transplants exacerbate l-DOPA-induced dyskinesia in a rat model of Parkinson's disease
-
Carlsson T., Carta M., Winkler C., Björklund A., Kirik D. Serotonin neuron transplants exacerbate l-DOPA-induced dyskinesia in a rat model of Parkinson's disease. J Neurosci 2007, 27:8011-8022.
-
(2007)
J Neurosci
, vol.27
, pp. 8011-8022
-
-
Carlsson, T.1
Carta, M.2
Winkler, C.3
Björklund, A.4
Kirik, D.5
-
135
-
-
18244424280
-
Potential therapeutic use of the selective dopamine D1 receptor agonist, A-86929: an acute study in parkinsonian levodopa-primed monkeys
-
Grondin R., Bédard P.J., Britton D.R., Shiosaki K. Potential therapeutic use of the selective dopamine D1 receptor agonist, A-86929: an acute study in parkinsonian levodopa-primed monkeys. Neurology 1997, 49:421-426.
-
(1997)
Neurology
, vol.49
, pp. 421-426
-
-
Grondin, R.1
Bédard, P.J.2
Britton, D.R.3
Shiosaki, K.4
-
136
-
-
0025919702
-
Effect of D1 and D2 agonists and antagonists on dyskinesias produced by l-dopa in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys
-
Gomez-Mancilla B., Bédard P.J. Effect of D1 and D2 agonists and antagonists on dyskinesias produced by l-dopa in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys. J Pharmacol Exp Ther 1991, 259:409-413.
-
(1991)
J Pharmacol Exp Ther
, vol.259
, pp. 409-413
-
-
Gomez-Mancilla, B.1
Bédard, P.J.2
-
137
-
-
28144463965
-
Validation of the l-dopa-induced dyskinesia in the 6-OHDA model and evaluation of the effects of selective dopamine receptor agonists and antagonists
-
Monville C., Torres E.M., Dunnett S.B. Validation of the l-dopa-induced dyskinesia in the 6-OHDA model and evaluation of the effects of selective dopamine receptor agonists and antagonists. Brain Res Bull 2005, 68:16-23.
-
(2005)
Brain Res Bull
, vol.68
, pp. 16-23
-
-
Monville, C.1
Torres, E.M.2
Dunnett, S.B.3
-
138
-
-
0027496673
-
Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys
-
Blanchet P., Bédard P.J., Britton D.R., Kababian J.W. Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys. J Pharmacol Exp Ther 1993, 267:275-279.
-
(1993)
J Pharmacol Exp Ther
, vol.267
, pp. 275-279
-
-
Blanchet, P.1
Bédard, P.J.2
Britton, D.R.3
Kababian, J.W.4
-
139
-
-
67349158011
-
Evaluation of the D3 dopamine receptor selective antagonist PG01037 on l-dopa-dependent abnormal involuntary movements in rats
-
Kumar R., Riddle L., Griffen S.A., Grundt P., Newman A.H., Luedtke R.R. Evaluation of the D3 dopamine receptor selective antagonist PG01037 on l-dopa-dependent abnormal involuntary movements in rats. Neuropharmacology 2009, 56:944-955.
-
(2009)
Neuropharmacology
, vol.56
, pp. 944-955
-
-
Kumar, R.1
Riddle, L.2
Griffen, S.A.3
Grundt, P.4
Newman, A.H.5
Luedtke, R.R.6
-
140
-
-
72049118177
-
The selective D(3) receptor antagonist, S33084, improves parkinsonian-like motor dysfunction but does not affect l-DOPA-induced dyskinesia in 6-hydroxydopamine hemi-lesioned rats
-
Mela F., Millan M.J., Brocco M., Morari M. The selective D(3) receptor antagonist, S33084, improves parkinsonian-like motor dysfunction but does not affect l-DOPA-induced dyskinesia in 6-hydroxydopamine hemi-lesioned rats. Neuropharmacology 2010, 58:528-536.
-
(2010)
Neuropharmacology
, vol.58
, pp. 528-536
-
-
Mela, F.1
Millan, M.J.2
Brocco, M.3
Morari, M.4
-
141
-
-
78650804442
-
Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on l-dopa dependent animal involuntary movements in rats
-
Riddle L.R., Kumar R., Griffin S.A., Grundt P., Newman A.H., Luedtke R.R. Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on l-dopa dependent animal involuntary movements in rats. Neuropharmacology 2011, 60:284-294.
-
(2011)
Neuropharmacology
, vol.60
, pp. 284-294
-
-
Riddle, L.R.1
Kumar, R.2
Griffin, S.A.3
Grundt, P.4
Newman, A.H.5
Luedtke, R.R.6
-
142
-
-
34347357671
-
Critical involvement of cAMP/DARP-32 and extracellular signal-regulated protein kinase signaling in l-DOPA-induced dyskinesia
-
Santini E., Valjent E., Usiello A., Carta M., Borgkvist A., Girault J.A., et al. Critical involvement of cAMP/DARP-32 and extracellular signal-regulated protein kinase signaling in l-DOPA-induced dyskinesia. J Neurosci 2007, 27:6995-7005.
-
(2007)
J Neurosci
, vol.27
, pp. 6995-7005
-
-
Santini, E.1
Valjent, E.2
Usiello, A.3
Carta, M.4
Borgkvist, A.5
Girault, J.A.6
-
143
-
-
43749109162
-
The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of l-DOPA-induced abnormal involuntary movements in experimental Parkinson's disease
-
Schuster S., Nadjar A., Guo J.T., Li Q., Ittrich C., Hengerer B., Bezard E. The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of l-DOPA-induced abnormal involuntary movements in experimental Parkinson's disease. J Neurosci 2008, 28:4311-4316.
-
(2008)
J Neurosci
, vol.28
, pp. 4311-4316
-
-
Schuster, S.1
Nadjar, A.2
Guo, J.T.3
Li, Q.4
Ittrich, C.5
Hengerer, B.6
Bezard, E.7
-
144
-
-
70349572635
-
Inhibition of mTOR signaling in Parkinson's disease prevents l-DOPA-induced dyskinesia
-
Santini E., Heiman M., Greengard P., Valjent E., Fisone G. Inhibition of mTOR signaling in Parkinson's disease prevents l-DOPA-induced dyskinesia. Sci Signal 2009, 80:ra36.
-
(2009)
Sci Signal
, vol.80
-
-
Santini, E.1
Heiman, M.2
Greengard, P.3
Valjent, E.4
Fisone, G.5
-
145
-
-
4544255049
-
Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease
-
Fox S., Silverdale M., Kellet M., Davies R., Steiger M., Fletcher N., et al. Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease. Mov Disord 2004, 19:554-560.
-
(2004)
Mov Disord
, vol.19
, pp. 554-560
-
-
Fox, S.1
Silverdale, M.2
Kellet, M.3
Davies, R.4
Steiger, M.5
Fletcher, N.6
-
146
-
-
79959365207
-
The selective mu-opioid receptor antagonist ADL5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in MPTP-lesioned macaque model of Parkinson's disease
-
Koprich J.B., Fox S.H., Johnston T.H., Goodman A., Le Bourdonnec B., Dolle R.E., et al. The selective mu-opioid receptor antagonist ADL5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in MPTP-lesioned macaque model of Parkinson's disease. Mov Disord 2011, 26:1225-1233.
-
(2011)
Mov Disord
, vol.26
, pp. 1225-1233
-
-
Koprich, J.B.1
Fox, S.H.2
Johnston, T.H.3
Goodman, A.4
Le Bourdonnec, B.5
Dolle, R.E.6
-
147
-
-
70349094450
-
TRK-820, a selective kappa opioid receptor agonist, could effectively ameliorate l-DOPA-induced dyskinesia symptoms in a rat model of Parkinson's disease
-
Ikeda K., Yoshikawa S., Kurokawa T., Yuzawa N., Nakao K., Mochizuki H. TRK-820, a selective kappa opioid receptor agonist, could effectively ameliorate l-DOPA-induced dyskinesia symptoms in a rat model of Parkinson's disease. Eur J Pharmacol 2009, 620:42-48.
-
(2009)
Eur J Pharmacol
, vol.620
, pp. 42-48
-
-
Ikeda, K.1
Yoshikawa, S.2
Kurokawa, T.3
Yuzawa, N.4
Nakao, K.5
Mochizuki, H.6
-
148
-
-
34548848043
-
Blockade of cannabinoid type 1 receptors augments the antiparkinsonian action of levodopa without affecting dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys
-
Cao X., Liang L., Hadcock J.R., Iredale P.A., Griffith D.A., Menniti F.S., et al. Blockade of cannabinoid type 1 receptors augments the antiparkinsonian action of levodopa without affecting dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys. J Pharmacol Exp Ther 2007, 323:318-326.
-
(2007)
J Pharmacol Exp Ther
, vol.323
, pp. 318-326
-
-
Cao, X.1
Liang, L.2
Hadcock, J.R.3
Iredale, P.A.4
Griffith, D.A.5
Menniti, F.S.6
-
149
-
-
35348938494
-
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors
-
Morgese M.G., Cassano T., Cuomo V., Giuffida A. Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors. Exp Neurol 2007, 208:110-119.
-
(2007)
Exp Neurol
, vol.208
, pp. 110-119
-
-
Morgese, M.G.1
Cassano, T.2
Cuomo, V.3
Giuffida, A.4
-
150
-
-
0035846577
-
Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study
-
Sieradzan K.A., Fox S.H., Hill M., Dick J.P., Crossman A.R., Brotchie J.M. Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study. Neurology 2001, 57:2108-2111.
-
(2001)
Neurology
, vol.57
, pp. 2108-2111
-
-
Sieradzan, K.A.1
Fox, S.H.2
Hill, M.3
Dick, J.P.4
Crossman, A.R.5
Brotchie, J.M.6
-
151
-
-
2342450729
-
Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study)
-
Olanow C.W., Damier P., Goetz C.G., Mueller T., Nutt J., Rascol O., et al. Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study). Clin Neuropharmacol 2004, 27:58-62.
-
(2004)
Clin Neuropharmacol
, vol.27
, pp. 58-62
-
-
Olanow, C.W.1
Damier, P.2
Goetz, C.G.3
Mueller, T.4
Nutt, J.5
Rascol, O.6
-
152
-
-
48749125932
-
A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model
-
Vanover K.E., Betz A.J., Weber S.M., Bibbiani F., Kielaite A., Weiner D.M., et al. A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model. Pharmacol Biochem Behav 2008, 90:540-544.
-
(2008)
Pharmacol Biochem Behav
, vol.90
, pp. 540-544
-
-
Vanover, K.E.1
Betz, A.J.2
Weber, S.M.3
Bibbiani, F.4
Kielaite, A.5
Weiner, D.M.6
-
153
-
-
0037345646
-
Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia
-
Lundblad M., Vaudano E., Cenci M.A. Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia. J Neurochem 2003, 84:1398-1410.
-
(2003)
J Neurochem
, vol.84
, pp. 1398-1410
-
-
Lundblad, M.1
Vaudano, E.2
Cenci, M.A.3
-
154
-
-
33845899095
-
Forebrain adenosine A2A receptors contribute to l-3,4-dihydroxyphenylalanine-induced dyskinesia in hemiparkinsonian mice
-
Xiao D., Bastia E., Xu Y.H., Benn C.L., Cha J.H., Peterson T.S., et al. Forebrain adenosine A2A receptors contribute to l-3,4-dihydroxyphenylalanine-induced dyskinesia in hemiparkinsonian mice. J Neurosci 2006, 26:13548-13555.
-
(2006)
J Neurosci
, vol.26
, pp. 13548-13555
-
-
Xiao, D.1
Bastia, E.2
Xu, Y.H.3
Benn, C.L.4
Cha, J.H.5
Peterson, T.S.6
-
155
-
-
52649088408
-
Continuous and intermittent nicotine treatment reduces l-3,4-dihyroxyphenylalanine (l-DOPA)-induced dyskinesias in a rat model of Parkinson's disease
-
Bordia T., Campos C., Huang L., Quick M. Continuous and intermittent nicotine treatment reduces l-3,4-dihyroxyphenylalanine (l-DOPA)-induced dyskinesias in a rat model of Parkinson's disease. J Pharmacol Exp Ther 2008, 327:239-247.
-
(2008)
J Pharmacol Exp Ther
, vol.327
, pp. 239-247
-
-
Bordia, T.1
Campos, C.2
Huang, L.3
Quick, M.4
-
156
-
-
77952480048
-
Nicotinic receptor-mediated reduction in l-DOPA-induced dyskinesias may occur via desensitization
-
Bordia T., Campos C., McIntosh J.M., Quik M. Nicotinic receptor-mediated reduction in l-DOPA-induced dyskinesias may occur via desensitization. J Pharmacol Exp Ther 2010, 333:929-938.
-
(2010)
J Pharmacol Exp Ther
, vol.333
, pp. 929-938
-
-
Bordia, T.1
Campos, C.2
McIntosh, J.M.3
Quik, M.4
-
157
-
-
37849023463
-
Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys
-
Quik M., Cox H., Parameswaren N., O'Leary K., Langston J.W., Di Monte D. Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys. Ann Neurol 2007, 62:588-596.
-
(2007)
Ann Neurol
, vol.62
, pp. 588-596
-
-
Quik, M.1
Cox, H.2
Parameswaren, N.3
O'Leary, K.4
Langston, J.W.5
Di Monte, D.6
-
158
-
-
79551662648
-
Enhanced striatal cholinergic neuronal activity mediates l-DOPA-induced dyskinesia in parkinsonian mice
-
Ding Y., Won L., Britt J.P., Lim S.A., McGehee D.S., Kang U.J. Enhanced striatal cholinergic neuronal activity mediates l-DOPA-induced dyskinesia in parkinsonian mice. Proc Natl Acad Sci USA 2011, 108:840-845.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 840-845
-
-
Ding, Y.1
Won, L.2
Britt, J.P.3
Lim, S.A.4
McGehee, D.S.5
Kang, U.J.6
-
159
-
-
27744571228
-
Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD
-
Bibbiani F., Oh J.D., Kielaite A., Collins M.A., Smith C., Chase T.N. Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD. Exp Neurol 2005, 196:422-429.
-
(2005)
Exp Neurol
, vol.196
, pp. 422-429
-
-
Bibbiani, F.1
Oh, J.D.2
Kielaite, A.3
Collins, M.A.4
Smith, C.5
Chase, T.N.6
-
160
-
-
0029665122
-
Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys
-
Papa S.M., Chase T.N. Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys. Ann Neurol 1996, 39:574-578.
-
(1996)
Ann Neurol
, vol.39
, pp. 574-578
-
-
Papa, S.M.1
Chase, T.N.2
-
161
-
-
0034090891
-
AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys
-
Konitsiotis S., Blanchet P.J., Verhagen L., Lamers E., Chase T.N. AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys. Neurology 2000, 54:1589-1595.
-
(2000)
Neurology
, vol.54
, pp. 1589-1595
-
-
Konitsiotis, S.1
Blanchet, P.J.2
Verhagen, L.3
Lamers, E.4
Chase, T.N.5
-
162
-
-
0037041286
-
Comparison of the basal ganglia in rats, marmosets, macaques, baboons, and humans: volume and neuronal number for the output, internal relay, and striatal modulating nuclei
-
Hardman C.D., Henderson J.M., Finkelstein D.I., Horne M.K., Paxinos G., Halliday G.M. Comparison of the basal ganglia in rats, marmosets, macaques, baboons, and humans: volume and neuronal number for the output, internal relay, and striatal modulating nuclei. J Comp Neurol 2002, 445(3):238-255.
-
(2002)
J Comp Neurol
, vol.445
, Issue.3
, pp. 238-255
-
-
Hardman, C.D.1
Henderson, J.M.2
Finkelstein, D.I.3
Horne, M.K.4
Paxinos, G.5
Halliday, G.M.6
-
163
-
-
77952852437
-
Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss
-
Spieles-Engemann A.L., Behbehani M.M., Collier T.J., Wohlgenant S.L., Steece-Collier K., Paumier K., et al. Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss. Neurobiol Dis. 2010, 39(1):105-115.
-
(2010)
Neurobiol Dis.
, vol.39
, Issue.1
, pp. 105-115
-
-
Spieles-Engemann, A.L.1
Behbehani, M.M.2
Collier, T.J.3
Wohlgenant, S.L.4
Steece-Collier, K.5
Paumier, K.6
-
164
-
-
0029942444
-
Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the cavalieri and optical disector methods
-
Oorschot D.E. Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the cavalieri and optical disector methods. J Comp Neurol 1996, 366(4):580-599.
-
(1996)
J Comp Neurol
, vol.366
, Issue.4
, pp. 580-599
-
-
Oorschot, D.E.1
-
165
-
-
0036289385
-
Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs
-
Andersson C., Hamer R.M., Lawler C.P., Mailman R.B., Lieberman J.A. Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs. Neuropsychopharmacology 2002, 27(2):143-151.
-
(2002)
Neuropsychopharmacology
, vol.27
, Issue.2
, pp. 143-151
-
-
Andersson, C.1
Hamer, R.M.2
Lawler, C.P.3
Mailman, R.B.4
Lieberman, J.A.5
-
166
-
-
77957241252
-
Striatal volume changes in a rat model of childhood attention-deficit/hyperactivity disorder
-
Hsu J.W., Lee L.C., Chen R.F., Yen C.T., Chen Y.S., Tsai M.L. Striatal volume changes in a rat model of childhood attention-deficit/hyperactivity disorder. Psychiatry Res 2010, 179(3):338-341.
-
(2010)
Psychiatry Res
, vol.179
, Issue.3
, pp. 338-341
-
-
Hsu, J.W.1
Lee, L.C.2
Chen, R.F.3
Yen, C.T.4
Chen, Y.S.5
Tsai, M.L.6
-
167
-
-
0036307196
-
Dopaminergic synapses in the matrix of the ventrolateral striatum after chronic haloperidol treatment
-
Roberts R.C., Force M., Kung L. Dopaminergic synapses in the matrix of the ventrolateral striatum after chronic haloperidol treatment. Synapse 2002, 45(2):78-85.
-
(2002)
Synapse
, vol.45
, Issue.2
, pp. 78-85
-
-
Roberts, R.C.1
Force, M.2
Kung, L.3
-
168
-
-
0032865590
-
The substantia nigra of the human brain. I: Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry
-
Damier P., Hirsch E.C., Agid Y., Graybiel A.M. The substantia nigra of the human brain. I: Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain 1999, 122(Pt. 8):1421-1436.
-
(1999)
Brain
, vol.122
, Issue.PART. 8
, pp. 1421-1436
-
-
Damier, P.1
Hirsch, E.C.2
Agid, Y.3
Graybiel, A.M.4
-
169
-
-
0033591617
-
Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra
-
Ma S.Y., Ciliax B.J., Stebbins G., Jaffar S., Joyce J.N., Cochran E.J., Kordower J.H., Mash D.C., Levey A.I., Mufson E.J. Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra. J Comp Neurol 1999, 409(1):25-37.
-
(1999)
J Comp Neurol
, vol.409
, Issue.1
, pp. 25-37
-
-
Ma, S.Y.1
Ciliax, B.J.2
Stebbins, G.3
Jaffar, S.4
Joyce, J.N.5
Cochran, E.J.6
Kordower, J.H.7
Mash, D.C.8
Levey, A.I.9
Mufson, E.J.10
-
170
-
-
57749176448
-
Striatal volume differences between non-human and human primates
-
Yin D., Valles F.E., Fiandaca M.S., Forsayeth J., Larson P., Starr P., Bankiewicz K.S. Striatal volume differences between non-human and human primates. J Neurosci Methods 2009, 176(2):200-205.
-
(2009)
J Neurosci Methods
, vol.176
, Issue.2
, pp. 200-205
-
-
Yin, D.1
Valles, F.E.2
Fiandaca, M.S.3
Forsayeth, J.4
Larson, P.5
Starr, P.6
Bankiewicz, K.S.7
-
171
-
-
0028923635
-
Age, gender, and hemispheric differences in human striatum: a quantitative review and new data from in vivo MRI morphometry
-
Raz N., Torres I.J., Acker J.D. Age, gender, and hemispheric differences in human striatum: a quantitative review and new data from in vivo MRI morphometry. Neurobiol Learn Mem 1995, 63(2):133-142.
-
(1995)
Neurobiol Learn Mem
, vol.63
, Issue.2
, pp. 133-142
-
-
Raz, N.1
Torres, I.J.2
Acker, J.D.3
|